InvestorsHub Logo
Followers 74
Posts 1863
Boards Moderated 0
Alias Born 04/30/2011

Re: None

Thursday, 10/06/2016 1:49:15 PM

Thursday, October 06, 2016 1:49:15 PM

Post# of 8439
People are going a little crazy about this award. Rumors flying. It will support and enhance an area of research SYN had to do anyway, so big help there. But the CDC won't push 004 thru ph3 and FDA approval. Not the purpose of this award. The CDC did not get an early peek at undisclosed pending 2b 004 results before awarding this contract. The application was done in the spring and such info was unavailable, never mind the fact that such a move would be unethical and a credibility ruination for the company. The award was split between multiple applicants. Its not a huge amount of money. They haven't partnered with the CDC for 004 development.
They have a beneficial contract with the CDC that offers some financial support in researching 004 effect on the microbiome. It is a collaborative contract, meaning there will be exchange of information, which may include some of SYN's emerging intellectual property portfolio of 004. The contract surely protects SYN in this information exchange while adding to the CDC's intellectual research base. Its a great thing for both parties...but it's not the miraculous event some of todays message board posters are imagining.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News